Cite
HARVARD Citation
Persico, M. et al. (2019). Real‐life efficacy and safety of glecaprevir/pibrentasvir in HCV‐infected patients with chronic kidney disease. GastroHep. 1 (4), pp. 166-171. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Persico, M. et al. (2019). Real‐life efficacy and safety of glecaprevir/pibrentasvir in HCV‐infected patients with chronic kidney disease. GastroHep. 1 (4), pp. 166-171. [Online].